Top
Bluestem
  • Who We Are
  • Strategy
  • Portfolio
  • Newsroom
  • INVESTOR PORTAL 2025
Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL 2025/
iStock-645678506 dark.png
Bluestem

Newsroom

Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL 2025/

News From the Bluestem Team


April 18, 2018

Microinterventional endocapsular nucleus disassembly

April 18, 2018/ Michele Kleinwolterink

Novel technique and results of first-in-human randomised controlled study.

ianTECH shared this story on their miNews page from the British Journal of Ophthalmology (April 18, 2018).  Visit their site to read more.  

-Shared by Tyler Stowater, board observer of ianTECH, Inc.

April 18, 2018/ Michele Kleinwolterink/

Michele Kleinwolterink

  • ianTECH’s miLOOP Grabs Two “Best ...
  • Neurolens System Provides Relief ...

*Legal Disclaimer: NEWSROOM The content provided herein is for informational and convenience purposes only. The information provided on this website does not constitute an offer to buy or sell any securities or provide any form of investment advice.  Bluestem Capital Company, LLC assumes no responsibility nor makes any claims as to the quality, accuracy or usefulness of third-party linked content made available on this site.

Bluestem is the registered service mark of Bluestem Capital Company, LLC. All Rights Reserved.